ArticleFrontiers in oncology2023

Circulating tumor DNA determining hyperprogressive disease after CAR-T therapy alarms in DLBCL: a case report and literature review.

Jiajie He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.